Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Oncolytic Virus Therapy market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Oncolytic Virus Therapy market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
The Oncolytic Virus Therapy market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Oncolytic Virus Therapy products across developed and developing countries of the world.
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Oncolytic Virus Therapy products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Oncolytic Virus Therapy market.
To learn more about this report
Increasing research and development spending on Oncolytic Virus Therapy development has been the leading industry trend of Oncolytic Virus Therapy market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
To learn more about this report
| Report Attributes | Details |
| The market size value in 2021 | USD XX.XX Million |
| CAGR (2021 - 2028) | XX.XX % |
| The Revenue forecast in 2028 | USD XX.XX Million |
| Base year for estimation | 2021 |
| Historical data | 2018-2019 |
| Forecast period | 2022-2028 |
| Quantitative units |
|
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook | HSV-based Oncolytic Viruses, Adenoviruses-based Oncolytic Viruses, Vaccinia Virus-based Oncolytic Viruses, Vesicular Stomatitis Virus-based Oncolytic Viruses, Newcastle Disease Virus-based Oncolytic Viruses |
| By Application Outlook | Melanoma, Prostate Cancer, Breast Cancer, Ovarian Cancer, Others |
| Regional scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope | U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled | Amgen, Oncolytics Biotech, Viralytics, Transgene SA, Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics, Sorrento Therapeutics, Lokon Pharma, Genelux Corporation, Vyriad, TILT Biotherapeutics, Cold Genesys |
| Customization Available | Yes, the report can be tailored to meet your specific requirements. |
1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Information Procurement
1.2.1 Purchased Database
1.2.2 Eternity’s Internal Database
1.2.3 Secondary sources & third-party perspectives
1.2.4 Primary Research
1.3 Information analysis
1.4 Market formulation & data visualization
1.5 Data validation & publishing
2 Executive Summary
3 Oncolytic Virus Therapy Market Variables, Trends & Scope
3.1 Market Dynamics
3.1.1 Market Driver Analysis
3.1.2 Market Restraints
3.1.3 Market Challenge Analysis
3.1.4 Market Opportunities
3.1.5 Micro & Macro Indicator
3.2 Impact of COVID-19 Pandemic on Global Oncolytic Virus Therapy Market
3.2.1 Overview of Changing Landscape
3.2.2 Pre-covid & Post-Covid Market Analysis
3.3 Market Attractiveness Analysis
3.4 Regulatory Scenario
3.5 Industry Trend Analysis- Historic and Future Trend Assessment
3.6 Merger & Acquisition
3.7 New System Launch/Approvals
3.8 Market Analysis Tools
3.8.1 Porter’s Five Forces
3.8.2 PEST Analysis
3.8.3 Value Chain Analysis
3.9 Key Company Ranking Analysis, 2020
4 Global Oncolytic Virus Therapy Market Analysis and Forecast, By Type
4.1 Overview & Definition
4.2 Key Trends
4.3 Global Oncolytic Virus Therapy Market Value (US$ Mn) Forecast, by Type (2019 – 2028)
4.2.1 HSV-based Oncolytic Viruses
4.2.2 Adenoviruses-based Oncolytic Viruses
4.2.3 Vaccinia Virus-based Oncolytic Viruses
4.2.4 Vesicular Stomatitis Virus-based Oncolytic Viruses
4.2.5 Newcastle Disease Virus-based Oncolytic Viruses
4.4 Type Comparison Matrix
4.5 Global Oncolytic Virus Therapy Market Attractiveness, By Type
5 Global Oncolytic Virus Therapy Market Analysis and Forecast, By Application
5.1 Overview & Definition
5.2 Key Trends
5.3 Global Oncolytic Virus Therapy Market Value (US$ Mn) Forecast, by Application (2019 – 2028)
5.3.1 Melanoma
5.3.2 Prostate Cancer
5.3.3 Breast Cancer
5.3.4 Ovarian Cancer
5.3.5 Others
5.4 Application Comparison Matrix
5.5 Global Oncolytic Virus Therapy Market Attractiveness, by Application
6 Global Oncolytic Virus Therapy Market Analysis and Forecast, By Region
6.1 Overview & Definition
6.2 Key Trends
6.3 Global Oncolytic Virus Therapy Market Value (US$ Mn) Forecast, by Region (2019 – 2028)
6.4 North America
6.5 Europe
6.6 Asia Pacific
6.7 Latin America
6.8 Middle East & Africa
7 Global Oncolytic Virus Therapy Market Attractiveness, by Region
8 North America Oncolytic Virus Therapy Market Analysis and Forecast
8.1 Key Findings
8.2 North America Oncolytic Virus Therapy Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
8.2.1 HSV-based Oncolytic Viruses
8.2.2 Adenoviruses-based Oncolytic Viruses
8.2.3 Vaccinia Virus-based Oncolytic Viruses
8.2.4 Vesicular Stomatitis Virus-based Oncolytic Viruses
8.2.5 Newcastle Disease Virus-based Oncolytic Viruses
8.3 North America Oncolytic Virus Therapy Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
8.3.1 Melanoma
8.3.2 Prostate Cancer
8.3.3 Breast Cancer
8.3.4 Ovarian Cancer
8.3.5 Others
8.4 North America Oncolytic Virus Therapy Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
8.4.1 U.S.
8.4.2 Canada
8.4.3 Rest of North America
8.5 North America Oncolytic Virus Therapy Market Attractiveness Analysis
8.5.1 By Type
8.5.2 By Application
8.5.3 By Country
9 Europe Oncolytic Virus Therapy Market Analysis and Forecast
9.1 Key Findings
9.2 Europe Oncolytic Virus Therapy Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
9.2.1 HSV-based Oncolytic Viruses
9.2.2 Adenoviruses-based Oncolytic Viruses
9.2.3 Vaccinia Virus-based Oncolytic Viruses
9.2.4 Vesicular Stomatitis Virus-based Oncolytic Viruses
9.2.5 Newcastle Disease Virus-based Oncolytic Viruses
9.3 Europe Oncolytic Virus Therapy Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
9.3.1 Melanoma
9.3.2 Prostate Cancer
9.3.3 Breast Cancer
9.3.4 Ovarian Cancer
9.3.5 Others
9.4 Europe Oncolytic Virus Therapy Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
9.4.1 U.K.
9.4.2 Germany
9.4.3 France
9.4.4 Italy
9.4.5 Rest of Europe
9.5 Europe Oncolytic Virus Therapy Market Attractiveness Analysis
9.5.1 By Type
9.5.2 By Application
9.5.3 By Country
10 Asia Pacific Oncolytic Virus Therapy Market Analysis and Forecast
10.1 Key Findings
10.2 Asia Pacific Oncolytic Virus Therapy Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
10.2.1 HSV-based Oncolytic Viruses
10.2.2 Adenoviruses-based Oncolytic Viruses
10.2.3 Vaccinia Virus-based Oncolytic Viruses
10.2.4 Vesicular Stomatitis Virus-based Oncolytic Viruses
10.2.5 Newcastle Disease Virus-based Oncolytic Viruses
10.3 Asia Pacific Oncolytic Virus Therapy Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
10.3.1 Melanoma
10.3.2 Prostate Cancer
10.3.3 Breast Cancer
10.3.4 Ovarian Cancer
10.3.5 Others
10.4 Asia Pacific Oncolytic Virus Therapy Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Asia Pacific Oncolytic Virus Therapy Market Attractiveness Analysis
10.5.1 By Type
10.5.2 By Application
10.5.3 By Country
11 Latin America Oncolytic Virus Therapy Market Analysis and Forecast
11.1 Key Findings
11.2 Latin America Oncolytic Virus Therapy Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
11.2.1 HSV-based Oncolytic Viruses
11.2.2 Adenoviruses-based Oncolytic Viruses
11.2.3 Vaccinia Virus-based Oncolytic Viruses
11.2.4 Vesicular Stomatitis Virus-based Oncolytic Viruses
11.2.5 Newcastle Disease Virus-based Oncolytic Viruses
11.3 Latin America Oncolytic Virus Therapy Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
11.3.1 Melanoma
11.3.2 Prostate Cancer
11.3.3 Breast Cancer
11.3.4 Ovarian Cancer
11.3.5 Others
11.4 Latin America Oncolytic Virus Therapy Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
11.4.1 Brazil
11.4.2 Rest of Latin America China
11.5 Latin America Oncolytic Virus Therapy Market Attractiveness Analysis
11.5.1 By Type
11.5.2 By Application
11.5.3 By Country
12 Middle East & Africa (MEA) Oncolytic Virus Therapy Market Analysis and Forecast
12.1 Key Findings
12.2 Middle East & Africa (MEA) Oncolytic Virus Therapy Market Analysis (US$ Mn) and Forecast, By Product Type (2019-2028)
12.2.1 HSV-based Oncolytic Viruses
12.2.2 Adenoviruses-based Oncolytic Viruses
12.2.3 Vaccinia Virus-based Oncolytic Viruses
12.2.4 Vesicular Stomatitis Virus-based Oncolytic Viruses
12.2.5 Newcastle Disease Virus-based Oncolytic Viruses
12.3 Middle East & Africa (MEA) Oncolytic Virus Therapy Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
12.3.1 Melanoma
12.3.2 Prostate Cancer
12.3.3 Breast Cancer
12.3.4 Ovarian Cancer
12.3.5 Others
12.4 Middle East & Africa (MEA) Oncolytic Virus Therapy Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
12.4.1 GCC Countries
12.4.2 South Africa
12.4.3 Rest of MEA
12.5 Middle East & Africa (MEA) Oncolytic Virus Therapy Market Attractiveness Analysis
12.5.1 By Type
12.5.2 By Application
12.5.3 By Country
13 Competitive Landscape
13.1 Market Players – Competition Matrix
13.2 Market Share Analysis by Key Players, 2020 (%)
13.3 Company Profiles
13.3.1 Amgen
13.3.1.1 Company Overview
13.3.1.2 Company Snapshot
13.3.1.3 Financial Overview
13.3.1.4 Product Portfolio
13.3.1.5 Key Developments/Strategies
13.3.2 Oncolytics Biotech
13.3.3 Viralytics
13.3.4 Transgene SA
13.3.5 Oncolys BioPharma
13.3.6 Targovax
13.3.7 PsiOxus Therapeutics
13.3.8 SillaJen Biotherapeutics
13.3.9 Sorrento Therapeutics
13.3.10 Lokon Pharma
13.3.11 Genelux Corporation
13.3.12 Vyriad
13.3.13 TILT Biotherapeutics
13.3.14 Cold Genesys
14 Key Takeaways
Choose License Type